Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma–COPD overlap syndrome

References

• Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (Updated 2016) Available from: http://www.goldcopd.orgAccessed August 1, 2016
   Google Scholar
• Global Initiative for AsthmaGlobal Strategy for Asthma Management and Prevention (Updated 2016) Available from: http://ginasthma.org/Accessed August 1, 2016
   Google Scholar
• MarshSETraversJWeatherallMProportional classifications of COPD phenotypesThorax200863976176718728201
   PubMed Web of Science ®Google Scholar
• HardinMSilvermanEKBarrRGThe clinical features of the overlap between COPD and asthmaRespir Res20111212721951550
   PubMed Web of Science ®Google Scholar
• GibsonPGMcDonaldVMAsthma-COPD overlap 2015: now we are sixThorax201570768369125948695
   PubMed Web of Science ®Google Scholar
• MiravitllesMSorianoJBAncocheaJCharacterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health statusRespir Med201310771053106023597591
   PubMed Web of Science ®Google Scholar
• HardinMChoMMcDonaldMLThe clinical and genetic features of COPD-asthma overlap syndromeEur Respir J201444234135024876173
   PubMed Web of Science ®Google Scholar
• MenezesAMMontes de OcaMPerez-PadillaRIncreased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthmaChest2014145229730424114498
   PubMed Web of Science ®Google Scholar
• SinDDMiravitllesMManninoDMWhat is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussionEur Respir J201648366467327338195
   PubMed Web of Science ®Google Scholar
• KitaguchiYKomatsuYFujimotoKHanaokaMKuboKSputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthmaInt J Chron Obstruct Pulmon Dis2012728328922589579
   PubMed Web of Science ®Google Scholar
• ParkTSLeeJSSeoJBStudy design and outcomes of Korean Obstructive Lung Disease (KOLD) Cohort StudyTuberc Respir Dis (Seoul)201476416917424851130
   PubMedGoogle Scholar
• MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
   PubMed Web of Science ®Google Scholar
• ChoJKPaekDYLeeJONormal predicted values of spirometry in Korean populationTuberc Respir Dis200558230242
   Google Scholar
• OhYMJeongBHWooSYAssociation of plasma adipokines with chronic obstructive pulmonary disease severity and progressionAnn Am Thorac Soc20151271005101226010877
   PubMed Web of Science ®Google Scholar
• GevenoisPAde MaertelaerVDe VuystPZanenJYernaultJCComparison of computed density and macroscopic morphometry in pulmonary emphysemaAm J Respir Crit Care Med199515226536577633722
   PubMed Web of Science ®Google Scholar
• LeeJSHuhJWChaeEJDifferent therapeutic responses in chronic obstructive pulmonary disease subgroupsInt J Tuberc Lung Dis20111581104111021740676
   PubMed Web of Science ®Google Scholar
• ParkHYLeeHKohWJAssociation of blood eosinophils and plasma periostin with FEV1 response after 3-month inhaled corticosteroid and long-acting beta2-agonist treatment in stable COPD patientsInt J Chron Obstruct Pulmon Dis201611233026730185
   PubMed Web of Science ®Google Scholar
• GartlehnerGHansenRACarsonSSLohrKNEfficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomesAnn Fam Med20064325326216735528
   PubMed Web of Science ®Google Scholar
• JonesPWWillitsLRBurgePSCalverleyPMDisease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbationsEur Respir J2003211687312570111
   PubMed Web of Science ®Google Scholar
• BurgePSCalverleyPMJonesPWSpencerSAndersonJAMaslenTKRandomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trialBMJ200032072451297130310807619
   PubMed Web of Science ®Google Scholar
• Lung Health Study Research GroupEffect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary diseaseN Engl J Med2000343261902190911136260
   PubMed Web of Science ®Google Scholar
• VestboJSorensenTLangePBrixATorrePViskumKLong-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trialLancet199935391671819182310359405
   PubMed Web of Science ®Google Scholar
• KewKMSeniukovichAInhaled steroids and risk of pneumonia for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20143CD010115
   PubMed Web of Science ®Google Scholar
• PriceDWestDBrusselleGManagement of COPD in the UK primary-care setting: an analysis of real-life prescribing patternsInt J Chron Obstruct Pulmon Dis2014988990425210450
   PubMed Web of Science ®Google Scholar
• VestboJVogelmeierCSmallMHigginsVUnderstanding the GOLD 2011 Strategy as applied to a real-world COPD populationRespir Med2014108572973624675239
   PubMed Web of Science ®Google Scholar
• WurstKERheaultTREdwardsLTal-SingerRAgustiAVestboJA comparison of COPD patients with and without ACOS in the ECLIPSE studyEur Respir J20164751559156226989103
   PubMed Web of Science ®Google Scholar
• YooKHSmoking cessation and chronic obstructive pulmonary diseaseKorean J Intern Med201530216316625750556
   PubMed Web of Science ®Google Scholar
• RheeCKYoonHKYooKHMedical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthmaCOPD201411216317024111662
   PubMedGoogle Scholar
• LeighRPizzichiniMMMorrisMMMaltaisFHargreaveFEPizzichiniEStable COPD: predicting benefit from high-dose inhaled corticosteroid treatmentEur Respir J200627596497116446316
   PubMed Web of Science ®Google Scholar
• BrightlingCEMcKennaSHargadonBSputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary diseaseThorax200560319319815741434
   PubMed Web of Science ®Google Scholar